pulmonary hypertension
pulmonary hypertension
Explore linked clinical trials. Standard reference: MONDO:0005149333 results · Page 1 of 14
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pulmonary Hypertension (PH) Biorepository for Translational Research | cardiovascular disorder, hypertensive disorder, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Not yet recruiting | Not stated | 2026-10-09 | NCT07647549 | |
| Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension | cardiovascular disorder, hypertensive disorder, interstitial lung disease, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Not applicable | 2026-10-09 | NCT06911632 | |
| A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038) | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Active, not recruiting | Phase 3 | 2026-10-08 | NCT07218029 | |
| A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY) | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cardiovascular disorder, central nervous system malformation, hereditary disease, hereditary sensory and autonomic neuropathy, hypertensive disorder, inherited neurodegenerative disorder, interstitial lung disease, lung disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Phase 2 | 2026-10-08 | NCT07175038 | |
| Prospective Evaluation of AI-ECG for SHD Detection | Deglutition Disorders, Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, digestive system disorder, disease, dyskinesia of esophagus, esophageal disorder, gastroesophageal reflux disease, heart disorder, heart failure, heart valve disorder, hypertensive disorder, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Not stated | 2026-10-08 | NCT07057466 | |
| Spironolactone for Pulmonary Arterial Hypertension | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 2 | 2026-10-08 | NCT01712620 | |
| A Clinical Study of Sotatercept (MK-7962) in People With Combined Postcapillary and Precapillary Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (MK-7962-041) | cardiovascular disorder, hypertensive disorder, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Not yet recruiting | Phase 3 | 2026-10-06 | NCT07839585 | |
| A Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-032) | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 2 | 2026-10-06 | NCT07646860 | |
| Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging | Lung Injury, acute lung injury, cardiovascular disorder, interstitial lung disease, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 3 | 2026-10-06 | NCT07613099 | |
| A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease | cardiovascular disorder, heart disorder, heart failure, hypertensive disorder, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Not applicable | 2026-10-06 | NCT07214376 | |
| PH-DyPred: A Multimodal Dynamic Risk Prediction Study in Pulmonary Hypertension | cardiovascular disorder, hypertensive disorder, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Not stated | 2026-10-06 | NCT07131241 | |
| Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, Infant, Premature, Diseases, Lung Injury, Ventilator-Induced Lung Injury, bronchopulmonary dysplasia, cardiovascular disorder, hypertensive disorder, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Not applicable | 2026-10-06 | NCT06373289 | |
| Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Active, not recruiting | Phase 3 | 2026-10-06 | NCT04273945 | |
| A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | Familial Primary Pulmonary Hypertension, Skin and Connective Tissue Diseases, cardiovascular disorder, connective tissue disorder, hypertensive disorder, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder, vascular disorder | Enrolling by invitation | Phase 3 | 2026-10-06 | NCT03683186 | |
| PET/MR Pre- and Post Radiotherapy for Cardiopulmonary Dysfunction Evaluation | cardiovascular disorder, hypertensive disorder, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Not applicable | 2026-10-05 | NCT04901884 | |
| A Study of Inhaled Treprostinil (LIQ861) in Adults With Pulmonary Arterial Hypertension Transitioning From Oral Selexipag | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 4 | 2026-10-02 | NCT07759804 | |
| Natural History Study of Biomarkers in Pulmonary Arterial Hypertension | cardiovascular disorder, hypertensive disorder, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Not stated | 2026-10-02 | NCT01730092 | |
| PAH-SDB: Sleep-Disordered Breathing and Outcomes in Pulmonary Arterial Hypertension | Apnea, Dyssomnias, Respiration Disorders, Sleep Disorders, Intrinsic, central sleep apnea syndrome, lung disorder, nervous system disorder, obstructive sleep apnea syndrome, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder | Recruiting | Not stated | 2026-10-01 | NCT07852403 | |
| Right Heart and Lung Blood Flow During Exercise (RIGHT-NET 2.0) | Ventricular Dysfunction, Ventricular Dysfunction, Right, cardiovascular disorder, cor pulmonale, heart disorder, hypertensive disorder, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Not yet recruiting | Not stated | 2026-10-01 | NCT07851610 | |
| Effect of Melatonin on Pulmonary Hypertension in Full Term Neonates | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hernia, Hernia, Diaphragmatic, Infant, Newborn, Diseases, Internal Hernia, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, congenital diaphragmatic hernia, lung disorder, persistent fetal circulation syndrome, pulmonary hypertension, respiratory system disorder | Recruiting | Not applicable | 2026-09-30 | NCT07850934 | |
| Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) | cardiovascular disorder, hypertensive disorder, interstitial lung disease, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Phase 3 | 2026-09-29 | NCT07179380 | |
| HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction | cardiovascular disorder, hypertensive disorder, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Phase 1 / Phase 2 | 2026-09-29 | NCT07123779 | |
| Microbiota Transplant With Antibiotic Preconditioning and Fiber Supplementation in PAH. | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Active, not recruiting | Phase 1 | 2026-09-28 | NCT07751120 | |
| Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH) | cardiovascular disorder, hypertensive disorder, lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Phase 2 | 2026-09-25 | NCT07318597 | |
| Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. | Arrhythmias, Cardiac, Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute coronary syndrome, cardiovascular disorder, heart disorder, hypertensive disorder, injury, lung disorder, myocardial ischemia, pulmonary hypertension, radiation injury, respiratory system disorder, vascular disorder | Recruiting | Not stated | 2026-09-25 | NCT07157670 |